A detailed history of Daiwa Securities Group Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 6,355 shares of CRL stock, worth $1.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,355
Previous 5,645 12.58%
Holding current value
$1.27 Million
Previous $1.17 Million 7.38%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $133,451 - $174,155
710 Added 12.58%
6,355 $1.25 Million
Q2 2024

Aug 07, 2024

BUY
$206.39 - $268.73 $120,118 - $156,400
582 Added 11.5%
5,645 $1.17 Million
Q1 2024

May 02, 2024

BUY
$203.52 - $273.43 $104,609 - $140,543
514 Added 11.3%
5,063 $1.37 Million
Q4 2023

Jan 31, 2024

BUY
$164.52 - $238.84 $43,597 - $63,292
265 Added 6.19%
4,549 $1.08 Million
Q3 2023

Nov 01, 2023

BUY
$194.44 - $217.61 $51,721 - $57,884
266 Added 6.62%
4,284 $840,000
Q2 2023

Jul 31, 2023

BUY
$183.71 - $210.25 $38,762 - $44,362
211 Added 5.54%
4,018 $845,000
Q1 2023

May 02, 2023

BUY
$191.89 - $259.92 $38,378 - $51,984
200 Added 5.54%
3,807 $768,000
Q4 2022

Feb 06, 2023

BUY
$197.11 - $250.07 $39,422 - $50,014
200 Added 5.87%
3,607 $786,000
Q3 2022

Nov 02, 2022

BUY
$182.44 - $250.54 $32,474 - $44,596
178 Added 5.51%
3,407 $670,000
Q2 2022

Aug 09, 2022

BUY
$204.13 - $302.4 $5,715 - $8,467
28 Added 0.87%
3,229 $691,000
Q1 2022

Apr 29, 2022

BUY
$255.51 - $362.11 $49,057 - $69,525
192 Added 6.38%
3,201 $909,000
Q4 2021

Feb 03, 2022

BUY
$351.38 - $448.68 $61,140 - $78,070
174 Added 6.14%
3,009 $1.13 Million
Q3 2021

Nov 05, 2021

BUY
$372.64 - $458.3 $20,867 - $25,664
56 Added 2.02%
2,835 $1.17 Million
Q2 2021

Aug 06, 2021

BUY
$294.17 - $371.65 $817,498 - $1.03 Million
2,779 New
2,779 $1.03 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.